Crilvastatin

This classification denotes a hmg-coa reductase inhibitor with the molecular formula C14H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D2B8XWK36K, more generally known as crilvastatin. European Medicines Agency schedules crilvastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06819MIG. The term CRILVASTATIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31. Most nations schedule crilvastatin under HS 29337900 and SITC 51561. As of Q4 2014, CRILVASTATIN remains the US FDA Preferred Term for this commodity. Crilvastatin bears US NLM identifiers UMLS ID C0217468 and NCI Concept Code C90865. SMILES: CC1CC(CC(C1)(C)C)OC(=O)C2CCC(=O)N2.